About Dr. Khanna: Rajesh Khanna, PhD, has a 20-year career in Neuroscience and Pharmacology. He was a doctoral student in the Department of Physiology at the University of Toronto, in Toronto, Canada. He was a Research Fellow in the David Geffen School of Medicine at the University of California at Los Angeles, in Los Angeles, UCLA; Assistant Staff Scientist, Toronto Western Research Institute, Toronto; and Assistant Professor, Indiana University School of Medicine. He is currently a tenured Professor of Pharmacology, Anesthesiology, and Neuroscience within the University of Arizona’s College of Medicine. His research intersects pain and neurodegenerative diseases and is focused on understanding mechanisms and developing strategies to allosterically regulate functions of key ion channels implicated in physiology and pathophysiology of pain and neurodegenerative diseases. Dr. Khanna is also the Chief Executive Officer and Co-founder of Regulonix, LLC, an Arizona startup focusing on novel chronic pain therapeutics and innovative biomarker technology development. Dr. Khanna’s research is funded by grants from the National Institutes of Health, The Department of Defense, and the Children’s Tumor Foundation
